Results 41 to 50 of about 9,852,504 (285)

Telemedicine Follow‐Up During Intensive Pediatric Cancer Treatment: Patient‐ and Family‐Reported Outcomes, Secondary Analysis of the KULT‐SH Trial

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children undergoing high‐intensity cancer therapy require frequent follow‐up visits due to the high risk of complications, which can place a substantial burden on patients and their families. Although telemedicine may reduce this burden, evidence on its use during the high‐intensity treatment phase in pediatric oncology is currently
Britta Exner   +9 more
wiley   +1 more source

Design and analysis strategies for robust microbiome ageing research

open access: yesFEBS Letters, EarlyView.
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik   +5 more
wiley   +1 more source

The EQ-5D-5L and Minimal Important Change in Long COVID

open access: yesAdvances in Rehabilitation Science and Practice
Introduction: The EQ-5D-5L is the most commonly used patient-reported outcome measure in Long COVID (LC). Despite its frequent use, there have been few studies reporting LC-specific metrics to identify and interpret meaningful change.
Adam B. Smith   +4 more
doaj   +1 more source

Going viral − Virus‐targeting nanobodies for research, diagnostics and therapy

open access: yesFEBS Letters, EarlyView.
The increasing prevalence of viral diseases represents a major threat for global human health. Nanobodies, small binding fragments derived from camelid heavy‐chain antibodies, offer versatile tools for viral research, diagnostics, and antiviral therapy.
Domenic Ebert, Ulrich Rothbauer
wiley   +1 more source

Neurostymulujące zestawy ćwiczeń fizycznych w przeciwdziałaniu long COVID [PDF]

open access: yes, 2021
The mankind has been fighting the coronavirus infection for almost two years. This is the first time the world is facing a pandemic of such a huge scale.
Shchadilova, Irina   +3 more
core   +1 more source

Experiences of pacing to reduce symptoms among adults living with Long COVID in Canada, Ireland, the United Kingdom and the United States

open access: yesDiscover Public Health
Background Long COVID is a multisystem condition that negatively impacts daily function. Pacing is a self-management strategy to mitigate symptoms. Our aim was to describe experiences of pacing from the perspectives of adults living with Long COVID ...
Kiera McDuff   +24 more
doaj   +1 more source

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

open access: yesMolecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche   +10 more
wiley   +1 more source

Delivery of DNA‐encoded vaccines and proteins in mice using cutaneous suction‐mediated transfection

open access: yesFEBS Open Bio, EarlyView.
Cutaneous suction‐mediated transfection in mice for delivery of DNA‐encoded vaccines and proteins. A critical limitation of DNA vaccines and other therapeutics is transfection in vivo to produce the encoded antigens or therapeutic proteins. Cutaneous suction‐based methods have demonstrated effectiveness in many animal models and have been successfully ...
Emran O. Lallow   +12 more
wiley   +1 more source

[The Long-COVID Syndrome - a New Clinical Picture after COVID-19 Infection]. [PDF]

open access: yes, 2021
The Long-COVID Syndrome - a New Clinical Picture after COVID-19 Infection Abstract. Long-term consequences are increasingly reported in the current literature after COVID-19 infections.
Funke-Chambour, Manuela   +13 more
core   +2 more sources

Identification of (20R)‐protopanaxadiol from Panax ginseng as a novel anti‐SARS‐CoV‐2 compound

open access: yesFEBS Open Bio, EarlyView.
We established a noninfectious BAC‐based SARS‐CoV‐2 replicon that enables antiviral screening under BSL‐2 conditions. Using this platform, we screened 373 food‐derived compounds and identified (20R)‐protopanaxadiol from Panax ginseng as a novel inhibitor of SARS‐CoV‐2 RNA replication, highlighting the value of safe replicon systems for antiviral ...
Midori Takeda   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy